<div id="readability-page-1">IN8bio (INAB) entered into a definitive securities purchase agreement for a private placement of up to ~$40.2M in gross proceeds, priced at-the-market. The initial tranche is expected to raise ~$20.1M and fund operations into the first half of 2027. At the initial closing, IN8bio will sell 5.13M shares at $1.38/share and pre-funded warrants for up ...</div>

INAB

<p>IN8bio announced a private placement agreement for up to $40.2M, with an initial tranche of $20.1M to fund operations until 2027. The company will sell shares and warrants at $1.38 each, with potential additional funds based on milestones. Proceeds will support studies and programs, with the initial closing expected by December 22, 2025. INAB shares rose 5% premarket.</p>

IN8bio announces up to $40.2M at-the-market private placement